Soy foods and health promotion

Vegetables, Fruits, and Herbs in Health Promotion

Volumn , Issue , 2000, Pages 117-134

  Anderson, James W ^a   Smith, Belinda M ^a   Moore, Kimberly A ^a   Hanna, Tammy J ^a  

^a LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011184401     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (106)

1. Messina, M., Messina, V., and Setchell, K.D.R., The Simple Soybean and Your Health, New York: Avery Publishing, 1994.
2. Young, V.R., Soy protein in relation to human protein and amino acid nutrition, J. Am. Diet. Assoc., 91, 828-835, 1991.
3. Makrides, M., Neumann, M., Simmer, K., Pater, J., and Gibson, R., Are long-chain polyunsaturated fatty acids essential nutrients in infancy?, Lancet, 345(8963), 1463-1468, 1995.
4. Ignatowski, A., Influence de la nourriture animale sur l’organisme des lapins, Arch. Med. Exp. Anat. Pathol., 20, 1-20, 1908.
5. Meeker, D.R. and Kesten, H.D., Experimental atherosclerosis and high protein diets, Proc. Exp. Biol. Med., 45, 543-545, 1940.
6. Sirtori, C.R., Agradi, E., Conti, F., Mantero, O., and Gatto, E., Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia, Lancet, 1, 275-277, 1977.
7. Anderson, J.W., Johnstone, B.M., and Cook-Newell, M.E., Meta-analysis of the effects of soy protein intake on serum lipids, NEJM, 333, 276-282, 1995.
8. Food and Drug Administration, HHS. Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease, Docket No. 98P-0683, 57700-57733. 99. 4160-01-P, Washington, D.C., 1999.
9. Anderson, J.J.B., Anthony, M., Messina, M., and Garner, S.C., Effects of phytooestrogens on tissues, Nutr. Res. Rev., 12, 75-116, 1999.
10. Haytowitz, D.B. and Mathews, R.H., Legume and legume products, U.S. Department of Agriculture, Washington, D.C., 1986.
11. Lo, G.S., Goldbert, A.P., Lim, A., Grundhauser, J.J., Anderson, C., and Schonfeld, G., Soy fiber improves lipid and carbohydrate metabolism in primary hyperlipidemic subjects, Atherosclerosis, 62, 239, 1986.
12. Anderson, J.W., Plant Fiber in Foods, Lexington, KY: HCF Nutrition Foundation, 1990.
13. Wang, H.J. and Murphy, P.A., Isoflavone composition of American and Japanese soybeans in Iowa; effects of variety, crop year, and location, J. Agric. Food Chem., 42, 1674, 1994.
14. Beecher, G.R., Bhagwat, S., Haytowitz, D., Holden, J.M., and Murphy, P.A., USDA Isoflavone Nutrient Database, 1999. Beltsville, MD, Beltsville Human Nutrition Research Center, ARS, USDA and Iowa State University Department of Food Science and Human Nutrition.
15. Foucard, T. and Yman, I.M., A study on severe food reactions in Sweden -is soy protein an underestimated cause of food anaphylaxis, Allergy, 54, 261-265, 1999.
16. Sicherer, S.H. and Sampson, H.A., Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management, J. Allerg. Clin. Immunol., 104, S114-S122, 1999.
17. Monere-Vautrin, D.A., Cow’s milk allergy, Allerg. Immunol., 31, 201-210, 1999.
18. Cantani, A. and Lucenti, P., Natural history of soy allergy and/or intolerance in children, and clinical use of soy-protein formulas, Pediatr. Allerg. Immunol., 8, 59-74, 1997.
19. Zoppi, G. and Guandalin, S., The story of soy formula feeding in infants: a road paved with good intentions, J. Pediatr. Gastroenterol. Nutr., 28(5), 541-543, 1999.
20. American Academy of Pediatrics -Committee on Nutrition. Soy protein-based formulas: Recommendations for use in infant feeding, Pediatrics, 101, 48-153, 1998.
21. Setchell, K.D.R., Simmer-Nechemias, L., Cai, J., and Helibi, J.E., Exposure of infants to phyto-estrogens from soy-based infant formulas, Lancet, 30, 23-27, 1997.
22. Jensen, K., Chemical substances harmful for the endocrine system, 7-23-1998, European Parliament.
23. Maldonado, J., Gil, A., Narbona, E., and Molina, J.A., Special formulas in infant nutrition: a review, Early Hum. Dev., 53, S23-S32, 1998.
24. Liener, I.E., Implications of antinutritional components in soybean foods, Crit. Rev. Food Sci. Nutr., 34(1), 31-67, 1994.
25. American Heart Association. 2000 Heart and Stroke Statistical Update. 1-32. 2000.
26. Gowri, M.S., Van der Westhuyzen, D.R., Bridges, S.R., and Anderson, J.W., Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL, Arterioscler. Thromb. Vasc. Biol., 9, 2226-2233, 1999.
27. Crouse, J.R. III, Morgan, T., Terry, J.G., Ellis, J., Vitolins, M., and Burke, G.L., A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins, Arch. Intern. Med., 159, 2070-2076, 1999.
28. Anthony, M.S., Clarkson, T.B., Bullock, B.C., and Wagner, JD., Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys, Arterioscler. Thromb. Vasc. Biol., 17(11), 2524-2531, 1997.
29. Anderson, J.W., Diwadkar, V.A., and Bridges, S.R., Selective effects of different antioxidants on oxidation of lipoproteins from rats, PSEBM, 218, 376-381, 1998.
30. Tikkanen, M.J., Wahala, K., Ojala, S., Vihma, V., and Aldercreutz, H., Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance, Proc. Natl. Acad. Sci., 95, 3106-3110, 1998.
31. Ross, R., Atherosclerosis is an inflammatory disease, Am. Heart J., 138, S419-S420, 1999.
32. Sadowska-Krowicka, H., Mannick, E.E., Oliver, P.D., Sandoval, M., Zhang, X.J., Eloby-Childess, S., Clark, D.A., and Miller, M.J.S., Genistein and gut inflammation: role of nitric oxide, Proc. Soc. Exp. Biol. Med., 217, 351-357, 1998.
33. Gooderham, J.M., Adlercreutz, H., Ojala, S., Wahala, K., and Holub, B.J., A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men, J. Nutr., 126, 2000-2006, 1996.
34. Wilcox, J.N. and Blumenthal, B.F., Thrombotic mechanism in atherosclerosis: potential impact of soy proteins, J. Nutr., 125, 631S-638S, 1995.
35. Honore, E.K., Williams, J.K., Anthony, M.S., and Clarkson, T.B., Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques, Fertil. Steril., 671(148), 154, 1997.
36. Nestel, P.J., Pomeroy, S., Kay, S., Komesaroff, P., Behrsing, J., Cameron, J.D., and West, L., Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women, J. Clin. Endocrinol. Metab., 84(3), 895-898, 1999.
37. Akiyama, S.K. and Yamada, K.M., Biosynthesis and acquisition of biological activity in fibronectin receptor, J. Biol. Chem., 262, 17536-17542, 1987.
38. Fotsis, T., Pepper, M., Adlercreutz, H., Hase, T., Montesano, R., and Schweigerer, L., Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis, J. Nutr., 125, 790S-797S, 1995.
39. Barnes, S., Effect of genistein on in vitro and in vivo models of cancers, J. Nutr., 125, 777S-783S, 1995.
40. Li, Y., Bhuiyan, M., and Sarkar, F.H., Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein, Int. J. Oncol., 15, 525-533, 1999.
41. Makela, S., Poutanen, M., Lehtimaki, J., Kostian, M.L., Santti, R., and Vihko, R., Estrogen-specific 17-beta-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens, Proc. Soc. Exp. Biol. Med., 208, 51-59, 1995.
42. Zhou, Y. and Lee, A.S., Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy, J. Natl. Cancer Inst., 90, 381-388, 1998.
43. Ji, S., Willis, G.M., Frank, R., Cornelius, S.G., and Spurlock, M.E., Soybean isoflavones, genistein and genistin, inhibit rat myoblast proliferation, fusion and myotube protein synthesis, J. Nutr., 129, 1291-1297, 1999.
44. Hawrylewicz, E.J., Zapata, J.J., and Blair, W.H., Soy and experimental cancer: animal studies, J. Nutr., 125, 698S-708S, 1995.
45. Davies, M.J., Bowey, E.A., Adelercreutz, H., Rowland, I.R., and Rumsby, P.C., Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats, Carcinogenesis, 20(6), 927-931, 1999.
46. Li, D., Yee, J.A., McGuire, M.H., Murphy, P.A., and Yan, L., Soybean isoflavones reduce experimental metastasis in mice, J. Nutr., 129, 1075-1078, 1999.
47. Appelt, L.C. and Reicks, M.M., Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats, J. Nutr., 129, 1820-1826, 1999.
48. Lamartiniere, C.A., Moore, J.B., Brown, N.M., Thompson, R., Hardin, M.J., and Barnes, S., Genistein suppresses mammary cancer in rats, Carcinogenesis, 16, 2833-2840, 1995.
49. Pollard, M., Prevention of prostate-related cancers in lobund-wistar rats, Prostate, 39, 305-309, 1999.
50. Steinmetz, K.A. and Potter, J.D., Vegetables, fruit and cancer prevention: a review, J. Am. Diet. Assoc., 96, 1027-1039, 1996.
51. Messina, M.J., Persky, V., Setchell, K.D.R., and Barnes, S., Soy intake and cancer risk: a review of the in vitro and in vivo data, Nutr. Cancer, 21, 113-131, 1994.
52. Goodman, M.T., Wilkens, L.R., Hankin, J.H., Lyu, L., Wu, A.H., and Kolonel, L.N., Association of soy and fiber consumption with the risk of endometrial cancer, Am. J. Epidemiol., 146, 294-306, 1997.
53. Ingram, D., Sanders, K., Koybab, M., and Lopez, D., Case-control study of phytooestrogens and breast cancer, Lancet, 350, 990-994, 1997.
54. Hebert, J.R., Hurley, T.G., Olendzki, B.C., Teas, J., Ma, Y., and Hampl, J.S., Nutritional and socioeconomic factors in relation to prostate cancer mortality: a crossnational study, J. Natl. Cancer Inst., 90, 1637-1647, 1998.
55. Strom, S.S., Yamamura, Y., Duphorne, C.M., Spitz, M.R., Babaian, R.J., Pillow, P.C., and Hursting, S.D., Phytoestrogen intake and prostate cancer: a case-control study using a new database, Nutr. Cancer, 33(1), 20-25, 1999.
56. Steele, V.E., Pereira, M.A., Sigman, C.C., and Kelloff, G.J., Cancer chemoprevention agent development strategies for genistein, J. Nutr., 125, 713S-716S, 1995.
57. Kennedy, A.R., The evidence for soybean products as cancer preventive agents, J. Nutr., 125, 733S-743S, 1995.
58. Chan, A.Y.M., Cheng, M.L.L., Keil, L.C., and Myers, B.D., Functional response of healthy and diseased glomeruli to a large, protein-rich meal, J. Clin. Invest., 81, 245-254, 1988.
59. Anderson, J.W., Blake, J.E., Turner, J., and Smith, B.M., Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes, Am. J. Clin. Nutr., 68(Suppl.), 1347S-1353S, 1998.
60. Hanna, T.J., Fanti, P., and Anderson, J.W., Soy protein decreases workload of kidneys in type 1 diabetics at risk for diabetic nephropathy, Proc. Soc. Exp. Biol. Med., 13(4), A272, 1999.
61. Fanti, P., Sawaya, B.P., Custer, L.J., and Franke, A.A., Serum levels and metabolic clearance of the isoflavones genistein and daidzein in hemodialysis patients, J. Am. Soc. Nephrol., 10, 864-871, 1999.
62. Ceballos-Picot, I., Witko-Sarsat, V., Merad-Boudia, M., Nguyen, A.T., Threvenin, M., Jungers, P., and Descamp-Latscha, B., Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure, Free Rad. Biol. Med., 21, 845-853, 1996.
63. Pereira, B.J.G., Shapiro, L., King, A.J., Fulagas, M.A., Storm, J.A., and Dinerello, C.A., Plasma levels of IL-1-alpha, TNF-alpha and their specific inhibitors in undialysed chronic renal failure, CAPD and hemodialysis patients, Kidney Intl., 45, 890-896, 1994.
64. Ogborn, M.R., Bankovic-Calic, N., Shoesmith, C., Buist, R., and Peeling, J., Soy protein modification of rat polycystic kidney disease, Am. J. Physiol., 274, F541-F549, 1998.
65. Aukema, H.M., Housini, I., and Rawling, J.M., Dietary soy protein effects on inherited polycystic kidney disease are influenced by gender and protein level, J. Am. Soc. Nephrol., 10, 300-308, 1999.
66. Tomobe, K., Philbrick, D.J., Ogborn, M.R., Takahashi, H., and Holub, B.J., Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease, Am. J. Kidney Dis., 31(1), 55-61, 1998.
67. Anderson, J.W., Nutritional management of diabetes mellitus, in Shils, M.E., Olson, J.A., Shike, M., Ross, A.C., and Young, V.A., Eds., Modern Nutrition in Health and Disease, Williams & Wilkins, Philadelphia, 1365-1394, 1998.
68. Anderson, J.W., Why do diabetic individuals eat so much protein and fat?, Med. Exerc. Nutr. Health, 2, 65-68, 1993.
69. Brezis, M., Silivia, P., and Epstein, F.H., Amino acids induce renal vasodilation in isolated perfused kidney, Am. J. Physiol., 253(F1083), F1090, 1984.
70. Kawata, Y., Mizukami, Y., Fujii, Z., Sakumura, T., Yoshida, K., and Matsuzaki, M., Applied pressure enhances cell proliferation through mitogen-activated protein kinase activation in mesangeal cells, J. Biol. Chem., 273, 16905-16912, 1998.
71. Hirikata, M., Kaname, S., Chung, U.G., Joki, N., Hori, Y., Noda, M., Takuwa, Y., Okazaki, T., Fujita, T., Katoh, T., and Kurokawa, K., Tyrosine kinase dependent expression of TGF-beta by stretch in mesangial cells, Kidney Int., 51, 1028-1036, 1997.
72. Gruden, G., Thomas, S., Burt, D., Lane, S., Chusney, G., Sacks, S., and Viberti, G.C., Mechanical stretch induces vascular permeability factor in human mesangeal cells: mechanism of signal transduction, Proc. Natl. Acad. Sci., 94, 12112-12116, 1997.
73. Huwiler, A., Van Rossum, G., Wartmann, M., and Pfeilschifter, J., Angiotensin II stimulation of stress-activated protein kinases in renal mesangial cells is mediated by the angiotensin AT1 receptor subtype, Eur. J. Pharmacol., 343, 297-302, 1998.
74. Pfeilschifter, J. and Huwiler, A., Nitric oxide stimulates stress-activated protein kinases in glomerular endothelial and mesangial cells, FEBS Lett., 396, 67-70, 1996.
75. Ha, H., Roh, D.D., Kirschenbaum, M.A., and Kamann, V.S., Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: role of protein tyrosine kinase and cyclic AMP-dependent protein kinase A, J. Lab. Clin. Med., 131(456), 465, 1998.
76. Gentile, M.G., Fellin, G., Cofano, F., Fave, A.D., Manna, G., Ciceri, R., Petrini, C., Lavarda, F., Pozzi, F., and D’Amico, G., Treatment of proteinuric patients with a vegetarian soy diet and fish oil, Clin. Nephrol., 40(6), 315-320, 1993.
77. Anthony, M.S., Clarkson, T.B., and Williams, J.K., Effects of soy isoflavones on atherosclerosis: potential mechanisms, Am. J. Clin. Nutr., 68(6 Suppl.), 1390S-1393S, 1998.
78. Kanazawa, T., Osanai, T., Zhang, X.S., Uemura, T., Yin, X.Z., and Onedera, K., Protective effects of soy protein on the peroxidizability of lipoproteins in cerebral vascular diseases, J. Nutr., 125, 639S-646S, 1995.
79. Chen, Z., Zheng, W., Custer, L.J., Dai, Q., Shu, X.O., Jin, F., and Franke, A.A., Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai, Nutr. Cancer, 33(1), 82-87, 1999.
80. Albertazzi, P., Pansini, F., Bonaccorsi, G., Zanotti, L., Forini, E., and De Aloysio, D., The effect of dietary soy supplementation on hot flushes, Obstet. Gynecol., 91, 6-11, 1998.
81. McNagny, S.E., Wenger, N.K., and Frank, E., Personal use of postmenopausal hormone replacement therapy by women physicians in the United States, Ann. Intern. Med., 127, 1093-1096, 1997.
82. Washburn, S., Burke, G.L., Morgan, T., and Anthony, M., Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women, J. Am. Menopause. Soc., 6(1), 7-13, 1999.
83. Murkies, A.L., Lombard, C., Strauss, B.J., Wilcox, G., Burger, H.G., and Morton, M.S., Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat, Maturitas, 21, 189-195, 1995.
84. Baird, D.D., Umbach, D.M., Lansdell, L., Hughes, C.L., Setchell, K.D., Weinberg, C.R., Haney, A.F., Wilcox, A.J., and Mclachlan, J.A., Dietary intervention study to assess the estrogenicity of dietary soy among postmenopausal women, J. Clin. Endocrinol. Metab., 80(5), 1685-1690, 1995.
85. National Osteoporosis Foundation. 1996 and 2015 Osteoporosis Prevalence Figures: State by State Report, Washington, D.C., 1997.
86. Nelson, M.E., Fiatarone, M.E., Morganti, C.M., Trice, I., Greenburg, R.A., and Evans, W.J., Effects of high intensity strength training on multiple factors for osteoporotic fractures: a randomized controlled trial, J. Am. Med. Assoc., 272, 1909-1914, 1994.
87. Riggs, B.L., A new option for treating osteoporosis, N. Engl. J. Med., 66, 140-146, 1990.
88. Breslau, N.A., Brinkley, L., Hill, K.D., and Pak, C.Y.C., Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism, J. Clin. Endocrinol. Metab., 66, 140-146, 1988.
89. Scheiber, M.D. and Rebar, R.W., Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?, Menopause, 6: 233-241, 1999.
90. Potter, S., Baum, J.A., Teng, H., Stillman, R.J., and Erdman, J.W., Soy protein and isoflavones: their effects on blood lipids and bone mineral density in postmenopausal women, Am. J. Clin. Nutr., 68, 1375S-1379S, 1998.
91. Ernst, R.L. and Hay, J.W., The U.S. economic and social costs of Alzheimer’s revisited, Am. J. Public Health, 84, 1261-1264, 1994.
92. Alzheimer’s Association. Alzheimer’s Disease Statistics Fact Sheet. 1997.
93. Evans, D.A., Estimated prevalence of Alzheimer’s disease in the U.S., Milbank Q., (68), 267-289, 1990.
94. American Diabetes Association. Diabetes Facts and Figures. 1999.
95. Shaywitz, S.E., Shaywitz, B.A., Pugh, K.R., Fulbright, R.K., Skudlarski, P., Mencl, W.E., Constable, R.T., Naftolin, F., Palter, S.F., Marchione, K.E., Katz, L., Shankweiler, D.P., Fletcher, J.M., Lacadie, C., Keltz, M., and Gore, J.C., Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks, J. Am. Med. Assoc., 281, 1197-1202, 1999.
96. Ciocca, D.R. and Vargas Roig, L.M., Estrogen receptors in human nontarget tissues: biological and clinical implications, Endocrine Rev., 16, 35-37, 1995.
97. Sherwin, B.B., Estrogen and cognitive functioning in women, Proc. Soc. Exp. Biol. Med., 217, 17-22, 1998.
98. Yaffe, K., Sawaya, G., Lieberburg, I., and Grady, D., Estrogen therapy in postmenopausal women: effects on cognitive function and dimentia, J. Am. Med. Assoc., 279, 688-695, 1998.
99. Waring, S.C., Rocca, W.A., Peterson, R.C., O’Brien, P.C., Tangalos, E.G., and Kokmen, E., Postmenopausal estrogen replacement therapy and risk of AD, Neurology, 52, 965-970, 1999.
100. Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J., Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor alpha and beta, Endocrinology, 138, 863-870, 1997.
101. Setchell, K.D.R. and Cassidy, A., Dietary isoflavones: biological effects and relevance to human health, J. Nutr., 129, 758S-767S, 1999.
102. White, L., Association of midlife tofu consumption with accelerated brain aging. Third Int. Symp. on the Role of Soy in Preventing and Treating Chronic Disease, 26-27, 1999.
103. Rice, M.M., Graves, A.B., McCurry, S.M., Gibbons, L., Bowen, J., McCormick, W., and Larson, E.B., Tofu consumption and cognition in older Japanese American Men and Women. Third Int. Symp. on the Role of Soy in Preventing and Treating Chronic Disease, 27, 1999.
104. Kim, H., Xia, H., Li, L., and Gewin, J., Modulation of neurodegeneration markers by dietary soy in a primate model of menopause. Third Int. Symp. on the Role of Soy in Preventing and Treating Chronic Disease, 27, 1999.
105. Pan, Y., Anthony, M., and Clarkson, T.B., Effect of estradiol and soy phytoestrogens on choline acetyltransfersase and nerve growth factor mRNA’s in the frontal cortex and hippocampus of female rats, PSEBM, 221, 118-125, 1999.
106. Weber, K.S., Jacobson, N.A., Setchell, K.D., and Lephart, E.D., Brain aromatase and 5-alpha-reductase, regulatory behaviors and testosterone levels in adult rats on phytoestrogen diets, Proc. Soc. Exp. Biol. Med., 221, 131-135, 1999.